Raymond Stevens

Ray Stevens is a biotech executive, company builder, and drug development operator with experience across CMC, IND strategy, translational development, clinical planning, commercialization, financing, and fundraising strategy. He helps early and mid stage life sciences companies convert complex science into credible, executable development plans.
Ray works with teams to clarify the next highest value experiment, pressure test regulatory, CMC, clinical, investor, and commercial assumptions, and identify the evidence needed to support financing, partnering, or development decisions. His work spans small molecule therapeutics, rare disease, ophthalmology, kidney injury, mitochondrial biology, formulation, manufacturing, and strategic fundraising.